Genetic Testing Market (By Technology: NGS, PCR-based Testing; By Application; By Product; By Channel: Online, Offline; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The global genetic testing market size was estimated at around USD 8.84 billion in 2023 and it is projected to hit around USD 64.73 billion by 2033, growing at a CAGR of 22.03% from 2024 to 2033.

Key Pointers

• North America led the market with the largest market share in 2023.
• By Technology, the next-generation sequencing (NGS) segment is expected to expand at the highest CAGR of 23.05% from 2024 to 2033.
• By Application, the health and wellness predisposition/risk/tendency segment generated the maximum market share of 48% in 2023.
• By Product, the consumables segment contributed the largest market share of 61% in 2023.
• By Channel, the online channel is anticipated to grow at the noteworthy CAGR of 24.08% from 2024 to 2033.
• By End-user, the hospitals and clinics segment had the largest market share of 47% in 2023.

Genetic Testing Market Overview

Genetic testing has emerged as a revolutionary tool in modern healthcare, offering valuable insights into an individual's genetic makeup and predisposition to various diseases and conditions. The global genetic testing market has witnessed significant growth in recent years, driven by advancements in technology, increasing awareness about personalized medicine, and rising demand for early disease detection and prevention.

Genetic Testing Market Growth Factors

The growth of the genetic testing market is propelled by several key factors. Firstly, technological advancements, particularly in next-generation sequencing and molecular diagnostics, have significantly improved the accuracy, speed, and affordability of genetic testing, making it more accessible to a broader population. Secondly, there is a growing demand for personalized medicine, which relies on genetic testing to tailor treatment plans based on an individual's genetic profile, leading to improved patient outcomes. Thirdly, the emphasis on early disease detection and prevention has increased, with genetic testing playing a crucial role in identifying genetic mutations and facilitating informed decision-making regarding treatment and management strategies. Lastly, the rising prevalence of genetic disorders worldwide has contributed to the expanding market for genetic testing services, as healthcare systems prioritize preventive healthcare measures. These factors collectively drive the growth of the genetic testing market, with further expansion expected as research and development efforts continue to enhance testing capabilities and applications.

Genetic Testing Market Trends:

• Rapid Technological Advancements: Continued advancements in technologies such as next-generation sequencing (NGS), microarray analysis, and polymerase chain reaction (PCR) are driving improvements in the accuracy, speed, and cost-effectiveness of genetic testing procedures.
• Expansion of Direct-to-Consumer (DTC) Testing: The proliferation of DTC genetic testing services is democratizing access to genetic information, allowing consumers to directly order tests without involving healthcare providers. This trend is reshaping traditional healthcare delivery models and raising questions about privacy, data security, and the interpretation of results.
• Integration of Artificial Intelligence (AI) and Machine Learning: AI and machine learning algorithms are being increasingly employed to analyze vast amounts of genetic data, enabling more accurate interpretation of results, identification of disease risk factors, and prediction of treatment responses. These technologies hold immense potential to enhance the efficiency and effectiveness of genetic testing processes.
• Rise of Precision Medicine Initiatives: Precision medicine approaches, which utilize genetic information to customize treatment plans for individual patients, are gaining momentum across various medical specialties. Genetic testing plays a central role in these initiatives by providing valuable insights into disease mechanisms, treatment efficacy, and patient prognosis.
• Expanded Applications Beyond Disease Diagnosis: Genetic testing is increasingly being utilized for non-medical purposes, including ancestry and genealogy tracing, personal wellness optimization, and lifestyle management. This diversification of applications is broadening the consumer base for genetic testing services and driving market growth.
• Regulatory and Ethical Considerations: As the genetic testing landscape evolves, regulatory bodies are grappling with issues related to test accuracy, clinical validity, and patient privacy. Ethical concerns surrounding the use of genetic information, including discrimination and stigmatization, are also shaping industry practices and regulations.

Technology Insights

The next-generation sequencing (NGS) segment is expected to experience rapid growth, with a projected Compound Annual Growth Rate (CAGR) of 23.05% from 2024 to 2033. This growth can be attributed to several factors, including the expansion of genome mapping initiatives, increased healthcare spending, technological advancements, and the broadening scope of applications for NGS technology. NGS technologies are increasingly utilized for the identification and characterization of various cancer types and genetic disorders. Genetic testing, facilitated by tumor DNA sequencing, plays a vital role in identifying unique DNA alterations associated with these conditions.

In the genetic testing industry, array technology is poised for significant growth. This can be attributed to the growing prevalence of cancer, leading to an increased adoption of DNA-based array technology for genetic disease diagnosis and personalized medicine. Array technology serves as a laboratory tool for studying the expression of multiple genes simultaneously. It involves the utilization of thousands of gene sequences on a gene chip. This technique finds extensive application in early-stage cancer detection, gene expression analysis, and drug discovery endeavors.

Application Insights

The health and wellness predisposition/risk/tendency segment held the largest market share of 48% globally in 2023 and is expected to maintain its dominance with the highest growth rate throughout the forecast period. There is a growing demand for predictive genetics and consumer/wellness genomics testing, driven by the increasing adoption of healthy lifestyles and awareness initiatives in the healthcare sector.

The genetic disease carrier status segment is also expected to witness significant growth in the market. These tests assess the likelihood of ancestral DNA matching known genomic information to the greatest extent possible. As genetics continues to evolve dynamically, an increasing number of individuals worldwide are opting for these tests. This surge in demand for carrier disease genetic testing is expected to further drive market growth.

Product Insights

In 2023, the consumables segment dominated the global genetic testing industry, holding a substantial share of 61%. This segment encompasses various players engaged in the supply and sale of consumables, offering a diverse range of products including reagents and accessories. The consumables market for genetic testing is poised for significant growth in the future, primarily due to the continuous and repetitive usage of these products throughout the testing process. Many competitors in the consumables market are actively pursuing both organic and inorganic growth strategies to augment their existing product portfolios and strengthen their geographic presence.

Similarly, the service segment is projected to experience notable growth during the forecast period. This growth is driven by increasing strategic initiatives by Contract Research Organizations (CROs), which are investing significantly in this segment. For instance, in January 2023, Inotiv Inc. bolstered its toxicology research capabilities by acquiring Integrated Laboratory System (ILS) for USD 56 million.

Channel Insights

The online channel is forecasted to exhibit the most rapid growth in the market, boasting a Compound Annual Growth Rate (CAGR) of 24.08%. This surge is largely propelled by the direct-to-consumer marketing strategy, fueled by increased research funding in molecular biology, a rising trend of direct-to-consumer testing, and heightened acceptance and awareness of personalized medicine. Direct-to-customer companies leverage over-the-counter and online channels to offer tests directly to consumers, ensuring easy accessibility.

On the other hand, the offline channel segment commanded the majority of the market share in 2023. The rapid development of new technologies in molecular genetic testing has facilitated the expansion of the testing industry. Moreover, a substantial number of private diagnostic laboratories continue to emerge, providing a diverse array of genetic testing solutions. A notable trend gaining momentum in molecular-based testing services is the offering of buccal swab collection kits and saliva for over-the-counter sales by pharmacies, further contributing to the growth of the offline channel segment.

End-user Insights

In 2023, the hospitals and clinics segment emerged as the leader in market revenue, capturing a significant share of 47%. This dominance is primarily attributed to mandatory newborn screening programs for genetic disorders and the escalating prevalence of cancer across various regions. Notably, in the United States, nearly 98% of women opt for hospital births, further driving the demand for genetic testing services. The anticipated expansion of hospital and clinic capacities is poised to further fuel this demand.

Furthermore, the adoption of recent trends such as telehealth and in-house hospital services is expected to bolster market growth. In December 2021, a U.S.-based healthcare company, Intermountain, witnessed a substantial surge in telehealth visits, soaring to over 73,000 per month from a mere 7,000 in March 2020. This trend was implemented across 225 clinics, 25 hospitals, and various partner hospitals, underscoring the growing reliance on telehealth services as a convenient and accessible healthcare solution.

Regional Insights

In 2023, North America emerged as the dominant force in the global market. This prominence can be attributed to several factors, including the escalating demand for diagnostics fueled by a rise in chronic illnesses and the availability of advanced diagnostic technologies. Additionally, the region's increasing incidence of infectious diseases such as COVID-19, tuberculosis, HIV, and influenza is expected to further drive demand for detection and treatment solutions. Moreover, the presence of well-established healthcare infrastructure and government funding for research initiatives are poised to contribute significantly to market growth in North America.

On the other hand, Asia Pacific stands out as the fastest-growing market, propelled by a substantial target population in countries like China, India, South Korea, and Japan. The region's rapid adoption of innovative laboratory techniques, including DNA sequencing, for the swift investigation and diagnosis of both chronic and infectious disorders is a key driver of market expansion. As such, Asia Pacific holds considerable potential for further growth and development in the diagnostics market.

Genetic Testing Market Key Companies

• 24 genetics
• Circle DNA
• Tellmegen
• 23andme
• AncestryDNA
• MyDNA
• Everly Well
• Igenomix
• VitaGen
• Myriad Genetics, Inc.
• Mapmygenome
• Helix OpCo LLC
• MyHeritage Ltd.
• Illumina, Inc.
• Color Genomics, Inc.
• Amgen, Inc.
• Beyond Nutrition Health and Wellness Services DMCC

Genetic Testing Market Segmentations:

By Technology

• Next Generation Sequencing
• Array Technology
• PCR-based Testing
• FISH
• Others

By Application

• Ancestry & Ethnicity
• Traits Screening
• Genetic Disease Carrier Status
• New Baby Screening
• Health and Wellness-Predisposition/Risk/Tendency

By Product

• Consumables
• Equipment
• Software & Services

By Channel

• Online
• Offline

By End-user

• Hospitals & Clinics
• Diagnostic Laboratories
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa